Press Releases 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals to Present at J.P. Morgan 34th Annual Healthcare Conference 12/29/15 Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula 12/24/15 Eagle Pharmaceuticals Reports Successful Outcomes from Safety and Efficacy Study of RYANODEX for Exertional Heat Stroke 12/17/15 Eagle Pharmaceuticals Achieves Milestone to Receive $15 Million Payment for Approval of BENDEKA 12/8/15 Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA™ (bendamustine hydrochloride) Injection 12/8/15 Eagle Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare Conference 11/23/15 Eagle Pharmaceuticals to Present at November Conferences 11/12/15 Eagle Pharmaceuticals, Inc. Reports Third Quarter 2015 Results 11/11/15 Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement 11/4/15 Eagle Pharmaceuticals to Discuss Third Quarter 2015 Financial Results on November 11, 2015 10/29/15 Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page
